Aldolase is a sensor for both low and high glucose, linking to AMPK and mTORC1 by Li, Mengqi et al.
                                                                    
University of Dundee
Aldolase is a sensor for both low and high glucose, linking to AMPK and mTORC1









Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Li, M., Zhang, C. S., Feng, J. W., Wei, X., Zhang, C., Xie, C., Wu, Y., Hawley, S. A., Atrih, A., Lamont, D. J.,
Wang, Z., Piao, H. L., Hardie, D. G., & Lin, S. C. (2020). Aldolase is a sensor for both low and high glucose,
linking to AMPK and mTORC1. Cell Research. https://doi.org/10.1038/s41422-020-00456-8
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 24. May. 2021
LETTER TO THE EDITOR OPEN
Aldolase is a sensor for both low and high glucose, linking to
AMPK and mTORC1
Cell Research (2020) 0:1–4; https://doi.org/10.1038/s41422-020-00456-8
Dear Editor,
As well as glucose being the major carbon nutrient for most
cells, its availability also acts as a gate-keeper exerting a switch
between anabolic and catabolic metabolism, with the protein
kinases mTORC1 and AMP-activated protein kinase (AMPK) being
the two master controllers.1 In low glucose, AMPK is activated and
phosphorylates a wide range of downstream targets to maintain
energy homeostasis, by switching on catabolic pathways while
switching off ATP-consuming processes.1 In high glucose,
mTORC1 is activated and shifts the metabolic program of the
cell towards anabolic metabolism.1 It is already known that low
glucose, and hence low levels of the glycolytic intermediate
fructose-1,6-bisphosphate (FBP), can be sensed by aldolase to
trigger AMPK activation via the lysosomal pathway.2,3 This occurs
independently of increases in AMP and ADP, the classical
activators of AMPK.2 Although it is clear that mTORC1 is also
regulated by glucose availability at multiple levels, the underlying
mechanisms have not been fully elucidated.
To maintain its activity, mTORC1 has to be located on the surface
of the lysosome, where it is activated by binding to two classes of
lysosome-localized small G proteins, i.e., Rheb and Rags. It has been
shown that the mTORC1:Rheb interaction is regulated by GAPDH:
when unoccupied by glyceraldehyde-3-phosphate (G3P), a glyco-
lytic metabolite downstream of FBP, GAPDH inhibits the ability of
Rheb to activate mTORC1.4 Rags are regulated by the Ragulator
complex, which is associated with the vacuolar ATPase (v-ATPase),
a multisubunit proton pump that hydrolyses ATP to provide the
energy to acidify the lumen of the lysosome.5 In high glucose, the
Ragulator converts RagA or RagB to their active GTP-bound forms,
triggering translocation of mTORC1 to the lysosome.6 In low
glucose, v-ATPase activity is inhibited, which in turn inhibits the
Ragulator.6 It is important to note that an active v-ATPase is
required to maintain the Ragulator activity, thus allowing the Rags
to activate mTORC1.5 However, how glucose is sensed and relayed
to the RAGs for mTORC1 activation has remained elusive.
We have previously shown that the lack of occupancy of
aldolase by FBP in low glucose triggers AMPK activation, which
prompted us to examine whether aldolase is also involved in the
activation of mTORC1 in high glucose. However, knocking down
all aldolases (ALDOA/ALDOB/ALDOC) in MEFs directly led to a
strong inhibition of the v-ATPase, as evidenced by a decreased
signal from LysoSensor Green DND-189 dye (Supplementary
information, Fig. S1a), indicating that lysosomal pH was raised.
This is consistent with previous findings that aldolase, as well as
being a glycolytic enzyme, is also an integral component of the v-
ATPase complex that is required for activity of the latter.7 The
intrinsic requirement of aldolase for the integrity of the v-ATPase
therefore precludes the use of ALDO knockdown or knockout
approaches to study regulation of mTORC1 by aldolase. We
utilized instead the D34S mutant of ALDOA, a mutation that does
not significantly affect initial Schiff base formation between FBP
and K230 of aldolase, but does block the carbon–carbon cleavage
that converts FBP to DHAP and G3P, which is mediated by D348
(Fig. 1a). This mutant therefore still binds FBP even in low glucose,
so that its expression mimics a high glucose state. We indeed
found that AMPK activation,2 as well as v-ATPase inhibition
(Supplementary information, Fig. S1b) was blocked in these cells,
regardless of the presence or absence of glucose in the medium.
By contrast, the K230A mutant fails to form a Schiff base with FBP,
thus preventing FBP binding.8 Expression of this mutant therefore
mimics a low glucose state and leads to constitutive activation of
AMPK.2 Expression of the D34S mutant in MEFs maintained the
activity of mTORC1 even in low glucose, while expression of
K230A caused inhibition of mTORC1 even in high glucose (Fig. 1b);
similar results were obtained in HEK293T cells (Fig. 1c).
Note that activated AMPK can inhibit mTORC1 by directly
phosphorylating its Raptor subunit, or TSC2, an upstream inhibitor
of Rheb, or ULK1 to inhibit Rags.1,9 Importantly, to exclude the
influence of AMPK, we also used AMPK-α1/2 DKO (double-
knockout) MEFs and AMPK-α1/2 DKD (double-knockdown)
HEK293T cells; the results confirmed that FBP-binding by aldolase
is able to control mTORC1 independently of AMPK (Fig. 1b, c). We
next examined whether the lysosomal localization of mTORC1
could be regulated by aldolase, and found that expression of the
D34S aldolase mutant retained the lysosomal localization of
mTORC1 in low glucose, while expression of the K230A mutant
caused dissociation from the lysosome even in high glucose
(Fig. 1d, e; Supplementary information, Fig. S2a, b). Similar results
were obtained in AMPK-α DKO/DKD cells (Fig. 1d, e; Supplemen-
tary information, Fig. S2a, b). We have previously shown that the
shortage of glucose (or more precisely FBP, after sensing by
aldolase) is relayed to the v-ATPase by inhibiting TRPV channels
acting upstream of it.10 Inhibition of TRPVs would also prevent
high glucose from maintaining mTORC1 activity. Indeed, TRPV
inhibitors AMG-9810 and BCTC, mimicking a low glucose state,
impaired the activity as well as the lysosomal localization of
mTORC1 in high glucose, in both WT and AMPKα1/2-DKO cells
(Fig. 1f, h; Supplementary information, Fig. S3a). Conversely,
activation of TRPV channels by agonists such as capsaicin (for
TRPV1) or GSK101 and RN1747 (for TRPV4) restored the activation
of mTORC1 in low glucose (Fig. 1g, h; Supplementary information,
Fig. S3a). In conclusion, we propose that aldolase acts as a sensor
for high glucose signalling to mTORC1.
It has been suggested that inactivation of v-ATPase by inactive
TRPV channels in low glucose leads to conformational changes of
the v-ATPase-Ragulator complex, providing a platform for AXIN
docking, where AXIN in turns undergoes conformational changes
for interacting with lysosomally localized AMPK.3,10 The conforma-
tional change of AXIN, an intrinsically disordered scaffold protein,
is supported by the results from the FRET–FLIM experiment
(Fig. 1i), which showed an increased fluorescence lifetime of the
donor (GFP fused to the N-terminus of AXIN), as a result of
decreased FRET between N- and C-termini of AXIN. Indeed, N-
terminally truncated AXIN-NT, which lacks intramolecular auto-
inhibition provided by the C-terminal domain, exhibits higher
affinity towards the v-ATPase and Ragulator than full-length
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AXIN.3 Interestingly, the autonomous binding of AXIN-NT to the
Ragulator–v-ATPase complex alone is sufficient to inhibit mTORC1
(Fig. 1j, k; Supplementary information, Fig. S3b), further indicating
that the lysosomal translocation of AXIN is a vital part of the
mechanism of mTORC1 inhibition in low glucose.3
As well as mTORC1 regulation by aldolase via sensing of
fluctuations in FBP (which decreases after glucose starvation by up
to 10-fold in MEFs and 5-fold in HEK293T cells, Supplementary
information, Fig. S4a, b; note that FBP, particularly in HEK293T cells,
should be determined by capillary electrophoresis-mass
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spectrometry (CE-MS), rather than high-performance liquid
chromatography-mass spectrometry (HPLC-MS) using pHILIC
columns for it fails to separate FBP from its isomers, see Supple-
mentary information, Fig. S4b–d), glucose may also be sensed by
other mechanisms to modulate mTORC1. As shown above,
expression of the ALDOA-D34S mutant maintains the activity of
mTORC1 even in low glucose, when GAPDH would be unoccupied
by G3P.4 This indicates that the Rag pathway for lysosomal
anchoring of mTORC1 cannot be over-ridden by unoccupied
GAPDH interfering with the interaction between mTORC1 and
Rheb. This also confirms that Rags play a dominant role in sensing
nutrient availability for activating mTORC1 as reported pre-
viously.11 However, the Rheb branch may play an augmentative
role to maintain the activity of mTORC1, particularly when the Rag
branch is disabled; in fact, Rheb has already been shown to play a
dominant role in the absence of the Rag pathway.12 Similarly,
exogenously supplied DHAP supports mTORC1 activation in cells
lacking aldolase,13 possibly by binding to GAPDH after conversion
to G3P. Since aldolase possesses bidirectional activity (Fig. 1a), the
ability of the ALDOA-D34S mutant to maintain mTORC1 activity
might also be attributed to its ability to bind DHAP in low glucose,
although we previously attributed this to binding of FBP only.
Evidence in support of this is that the K230 residue of the ALDOA-
D34S protein aldolase from starved cells could be detected in both
a phosphoglucitolylated (six-carbon, likely derived from FBP) and a
phosphoglycerolylated (three-carbon from DHAP) form by mass
spectrometry (Supplementary information, Fig. S4e). In addition,
binding of DHAP or FBP leads to similar structural changes in the
C-terminal tail of aldolase, which is required for the binding of
TRPV.10,14 Therefore, aldolase may also act as a sensor for DHAP to
regulate mTORC1. Remarkably, several other glycolytic enzymes
and their substrates/products also participate in regulating
mTORC1 in response to glucose availability at multiple sites
(Supplementary information, Fig. S5).
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Fig. 1 Aldolase is a sensor of glucose availability for mTORC1 regulation. a Schematic diagram of catalytic mechanisms of aldolase.8
b–e Expression of the D34S aldolase mutant retains mTORC1 activity in low glucose, while the K230A mutant inhibits mTORC1 even in high
glucose. Wild-type and AMPKα1/2-DKO MEFs (b, d), and wild-type and AMPKα1/2-DKD HEK293T cells (c, e) were infected with lentivirus
expressing HA-tagged ALDOA, the D34S or K230A mutants; the cells were then incubated in DMEM medium with 8mM glucose, or were
starved for glucose (GS) for 2 h. mTORC1 activity was assessed by determining of p-S6K and S6K levels by immunoblotting, followed by
densitometry analysis (b, c, data are means ± SEM, n= 3, with P values calculated by ANOVA). The lysosomal localization of mTOR (d, e) was
determined by immunofluorescent staining. mTOR, and the lysosomal marker LAMP2 (d) or LAMP1 (e) were stained, and Mander’s overlap
coefficients were plotted as means ± SD, n= 19–24, with P values calculated by ANOVA (see representative images in Supplementary
information, Fig. S2a, b). f–h Inhibition of TRPV impairs mTORC1 activity in high glucose, and activation of TRPV restores the mTORC1 activity
in low glucose. Wild-type and AMPKα-DKO MEFs were treated with 5 μM AMG-9810 (AMG) or 10 μM BCTC for 30min in DMEM medium
containing 8mM glucose (f, h), or glucose-starved for 2 h, followed by addition of 50 nM GSK101 (GSK), 100 nM capsaicin (Cap), or 0.7 μM
RN1747 (RN) for 15min (g, h). Levels of p-S6K and S6K were then determined by immunoblotting, followed by densitometry analysis (f, g, data
are means ± SEM, n= 4–6; P values were calculated by ANOVA). The localization of mTOR (h) was determined by immunofluorescent staining
as in (d), and Mander’s overlap coefficients were plotted as means ± SD, n= 20–26, with P values calculated by ANOVA (See representative
images in Supplementary information, Fig. S3a). i The conformation of AXIN, determined by FRET–FLIM, changes in response to low glucose.
MEFs were infected with lentivirus expressing AXIN1 tagged at the N-terminus with GFP (FRET donor) and at the C-terminus with mCherry
(FRET acceptor). The resultant AXIN1 construct was named the M2M4 mutant, which carries mutations in the DIX domain to prevent
intermolecular interactions,15 so that the FRET signals only reflect intramolecular interactions. Cells were incubated in DMEM medium with
8mM glucose, or starved for glucose (GS) for 2 h, and the fluorescent lifetimes of GFP were measured and plotted as means ± SD; n= 70 and
105 for cells incubated in 8mM and 0mM glucose, respectively. P values were calculated by Student’s t-test. j, k Expression of AXIN-NT inhibits
mTORC1 activity in high glucose. Wild-type and AMPKα-DKO MEFs with AXIN knockdown were infected with lentiviruses expressing HA-
tagged AXIN and AXIN-NT. Cells were incubated in DMEM medium with 8mM glucose. Levels of p-S6K and S6K were then determined by
immunoblotting, followed by densitometry analysis (j, data are means ± SEM, n= 3; P values were calculated by Student’s t-test). The
localization of mTOR (k) was determined by immunofluorescent staining as in (d), and Mander’s overlap coefficients were plotted as means ±
SD, n= 22–26 with P values by ANOVA (see representative images in Supplementary information, Fig. 3b). All experiments in this figure were
performed at least twice.
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